Dipal Doshi - Insider Trading & Ownership

Entity
Individual
Location
C/O Amicus Therapeutics, 1 Cedar Brook Drive, Cranbury, NJ
Summary
The estimated net worth of Dipal Doshi is at least $5.14M dollars as of February 11, 2025. Dipal Doshi is the CEO, Director of Entrada Therapeutics, Inc. and owns shares of Entrada Therapeutics, Inc. (TRDA) stock worth about $4.93M. Dipal Doshi is the Director of Azenta, Inc. and owns shares of Azenta, Inc. (AZTA) stock worth about $211K.
All Insider Reports
All Insider Reports

Ownership of Dipal Doshi

Insider Transactions Reported by Dipal Doshi:

* An asterisk sign (*) next to the price indicates that the price is likely invalid.